All Rankings

Top 100 Biotech Companies 2026

Private biotechnology and genomics companies, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $65.6B.

Showing top 100 matching companies · Ranked by total funding raised · Latest company record update Oct 3, 2026

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series DTotal funding$760.0MSep 2025
27
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
28
Beeline Medicines

Beeline Medicines is a clinical-stage biotechnology company developing precision therapies for pe...

Boston, United States11–50Biotech, Healthcare
Series ATotal funding$726.3MJul 2026
29
Solugen

Solugen manufactures lower-carbon specialty chemicals using its Bioforge platform, combining enzy...

Houston, United States51–200Biotech, Climate Tech
Venture RoundTotal funding$695.7MMar 2026
30
Kriya Therapeutics

Kriya integrates product engineering, analytics, and manufacturing to develop scalable gene thera...

Research Triangle Park, United StatesBiotech, Healthcare
Series DTotal funding$655.0MSep 2025
31
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
32
Celularity

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell ...

Florham Park, United States51–200Biotech, Healthcare
Extension RoundTotal funding$645.0MJan 2021
33
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series CTotal funding$643.0MMar 2021
34
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
35
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series ETotal funding$614.0MNov 2021
36
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series DTotal funding$610.3MSep 2026
37
TrialSpark

Clinical trial site network and operations

New York, United States51–200Biotech, Healthcare
Series CTotal funding$598.0MJan 2024
38
UPSIDE Foods

UPSIDE Foods grows cultivated chicken from animal cells in nutrient-fed tanks, producing real mea...

Berkeley, United States201–500Biotech, Food Tech
Series CTotal funding$583.0MApr 2022
39
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech
Series DTotal funding$583.0MSep 2025
40
Corxel

Biopharmaceutical company

United States51–200Biotech, Healthcare
Series DTotal funding$581.5MJan 2026
41
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series FTotal funding$575.0MJan 2026
42
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$572.6MJan 2025
43
Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech developing novel small molecule medicines using s...

Cambridge, United States51–200Biotech, Healthcare
Growth EquityTotal funding$572.0MSep 2023
44
DNAnexus

Provides a cloud-based precision-health platform to manage, analyze, and collaborate on multi-omi...

Mountain View, United States201–500Data & Analytics, Developer Tools
Series G+Total funding$572.0MMar 2022
45
Orca Bio

Orca Bio develops precision allogeneic cell therapies that use regulatory T cells to improve outc...

Menlo Park, United States51–200Biotech, Healthcare
Series FTotal funding$567.0MDec 2025
46
Freenome

Freenome develops blood-based cancer screening tests using computational biology, machine learnin...

South San Francisco, United States501–1000Artificial Intelligence, Biotech
Series ETotal funding$554.0MFeb 2024
47
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series FTotal funding$514.0MSep 2026
48
Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing innovative therap...

Westlake Village, United States51–200Biotech, Healthcare
Series DTotal funding$506.0MFeb 2026
49
Piramal Pharma

India-based pharmaceutical company offering CDMO services, critical care products, and consumer h...

Mumbai, India10001+Biotech, Healthcare
Corporate RoundTotal funding$490.0MJun 2020
50
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series DTotal funding$473.3MAug 2026